Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAPTIST: Broad-spectrum Antibiotic Prophylaxis in Orthopedic Surgery
NCT05502380Phase 3Recruiting
- Sponsor
- University Hospital Balgrist
- Start
- Sep 2022
- Primary completion
- Dec 2024
- Modality
- Nanoparticles, Implantable Devices, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of vancomycin, gentamicin in surgical site infection (SSI), sponsored by University Hospital Balgrist. Started Sep 2022; status: recruiting.
02
Drugs
vancomycingentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05502380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05502380.